These numbers characterize reported research handling and are shared solely for research-use-only, non-clinical purposes
McGraw-Hill / Lange rxlist.com (Januvia ) Keywords Saxagliptin Trade Name: Onglyza Mechanism of Action: a DPP-4 inhibitor, similar to Sitagliptin Pharmacokinetics: mixed renal & hepatic clearance dosage should be reduced in patients with moderate to severe renal impairment References: Masharani U, Kroon L (2024): Pancreatic Hormones & Antidiabetic Drugs (Chapter 41)
Physiol Rev 1980
A GLP-1 Vision Loss Lawsuit is a legal claim filed by individuals who have experienced sudden or permanent vision loss, such as non-arteritic anterior ischemic optic neuropathy (NAION), after using GLP-1 medications like Ozempic, Wegovy, Mounjaro, or Zepbound
The man, shirtless, has round patches on his chest where medical equipment connects, but he also sports a few LifeWave patches